BRINK, Prof Adrian
MBChB, MMed (Med Micro), Chair and Head of the Division of Medical Microbiology, Department of Pathology, Faculty of Health Sciences, and National Health Laboratory Services, Groote Schuur Hospital, University of Cape Town.

Research interests: The clinical and molecular epidemiology of antibiotic-resistant infections; the mechanisms of resistance as a confounder in antibiotic stewardship; the design and implementation of large-scale antibiotic stewardship and infection prevention and control interventions in low- and middle-income countries. The current focus also includes the functional composition of the human microbiome, including the resistome of the gastro-intestinal tract and the heart-GUT axis.

 


BOULLE, Prof Andrew
MBChB, MSc, PhD, FCPHM(SA). Division of Public Health Medicine and Centre for Infectious Disease Epidemiology and Research (CIDER), School of Public Health and Family Medicine; Wellcome Centre for Infectious Diseases Research in Africa (CIDRI-Africa), Institute of Infectious Disease and Molecular Medicine; Health Impact Assessment directorate, Department of Health, Provincial Government of the Western Cape. 

Research interests: HIV cohort and infectious disease epidemiology; operations research on service responses for priority health conditions; data harmonisation and linkage; and context-appropriate health information systems development.

 


DHEDA, Prof Keertan
Keertan Dheda (MBBCh (Wits), FCP (SA), FCCP, PhD (Lond)) is Head of the Lung Infection and Immunity Unit and Associate Professor of Respiratory Medicine (SARChI), Division of Pulmonology and UCT Lung Institute, Department of Medicine, University of Cape Town.

He holds an honorary faculty position at UCL. His group’s main research interests are the study of pulmonary regulatory immunological pathways in relation to infection, rapid and field-friendly diagnosis of tuberculosis, and drug-resistant tuberculosis. His work is funded by the SA MRC, SA NRF, EU FP7, EDCTP and NIH.

 


FAGAN-ENDRES, Dr Marijke
BSc (Chem) Eng UCT, PhD Cantab; Centre for Bioprocess Engineering Research (CeBER), Department of Chemical Engineering, Faculty of Engineering and the Built Environment, UCT.

Research interests: Production testing of microbial products including culturing, formulation, drying and shelf-life testing. Her current focus is on the development of probiotic products targeted at the treatment of bacterial vaginosis.

 


JOSEPH DAVEY, Dr Dvora
BA, MPH, PhD (Epidemiology). Honorary Senior Lecturer, School of Public Health and Family Medicine, Division of Epidemiology and Biostatistics, Desmond Tutu Health Foundation. 

Dvora is an Assistant Professor of Epidemiology at the University of California, Los Angeles. Her research focuses on evaluating innovative technologies and interventions to improve the delivery of HIV/STI prevention interventions (including pre-exposure prophylaxis) and treatment in sub-Saharan Africa, especially in pregnant women, male partners and families.  

 


MAARTENS, Prof Gary
MBChB, MMed, FCP SA DTM&H; Head of the Division of Clinical Pharmacology

His main research interests are in the therapeutic aspects of HIV-associated tuberculosis and drug-resistant tuberculosis, antiretroviral therapy in resource-limited settings, and the pharmacokinetics of antiretroviral and anti-tuberculosis drugs.

 


McILLERON, Prof Helen
MBChB(UCT), PhD in Clinical Pharmacology, Department of Medicine, University of  Cape Town.

Key research areas involve optimising doses and drug combinations for patients with drug-resistant tuberculosis or TB/HIV co-infection, and optimising anti-tuberculosis drug use in children. She participates in research projects across Africa, as well as in Asia and South America where a key interest is the support and mentoring of investigator-initiated pharmacology research projects.

 


MYER, Prof Landon
MBChB MA MPhil PhD; Professor, Centre for Infectious Diseases Epidemiology & Research, School of Public Health & Family Medicine

Thirty-one Masters students supervised; broad areas of research are: epidemiology of HIV/AIDS, other sexually transmitted infections & tuberculosis; maternal and child health; women's reproductive health.

 


NTSEKHE, Prof Mpiko
BA, MD, MPhil (Cardiol), PhD, FCP (SA), Cert Cardiol (SA), F.A.C.C.  Helen and Morris Maueberger Professor and Chair of Cardiology, Department of Medicine, University of Cape Town and Head: Division of Cardiology Groote Schuur Hospital.

Ongoing research: Investigation of the Management of Pericarditis (IMPI), Inflammatory determinants of disease severity and treatment outcome in TB patients, Left Cardiac Sympathetic Denervation for Cardiomyopathy Pilot Study, HIV Associated Myocardial Fibrosis Study.

 


SLIWA-HAHNLE, Prof Karen
Director, Hatter Institute for Cardiology Research; Diploma in Tropical Medicine and Hygiene, specialist physician, cardiologist (2000).

Is one of the very rare cardiologists in South Africa who is clinically active and trained in fundamental molecular laboratory methods, combining laboratory and epidemiological skills. Widely published in both local and international journals and books of various topics related to cardiovascular medicine. Internationally recognized for her outstanding work in the area of heart failure. Collaborations with a range of prestigious national and international clinical and academic centers. She holds an appointment as adjunct professor at the University of Queensland, Brisbane, Australia and as a visiting professor at the Baker Institute in Melbourne, Australia.

 


STEIN, Prof Dan
Professor and Head of Dept, Psychiatry and Mental Health; Chair in Psychiatry; Director, the Brain and Behaviour Initiative (BBI).

The Brain and Behaviour Initiative (BBI) enables cross-faculty, multidisciplinary, collaborative research in the cognitive and affective neurosciences and brings together expertise on phenotyping, genotyping, cognotyping, brain imaging and molecular signatures to address brain-behaviour issues. New experimental techniques including brain imaging, genetic testing and neuropsychological assessment combined with new theoretical insights have opened up significant potential for the advancement of novel diagnostic tools and treatments for people with mental disorders. The initial focus on trauma and resilience has now extended to work in substance use and NeuroHIV.

 


ZAR, Prof Heather
MBBCh, FAAP, PhD is head of Paediatric Pulmonology at Red Cross Childrens Hospital, University of Cape Town.

Her research focuses on child lung health including HIV-associated lung disease, childhood pneumonia and childhood TB. In 2014 she received the 2014 World Lung Health Award, awarded by the American Thoracic Society at a ceremony in San Diego, in recognition of work that has "the potential to eliminate gender, racial, ethnic, or economic health disparities worldwide".

 


ZÜHLKE, Assoc Prof Liesl
MBChB, DCH, MPH, PhD(Cape Town) FC Paeds, FESC, FACC. Paediatrician/Paediatric Cardiologist, Department of Paediatric Cardiology, Red Cross War Memorial Children’s Hospital; Director and Medical Specialist, Children’s Heart Disease Research Unit, UCT.

Currently regarded as a thought leader in Rheumatic Heart Disease, both on the continent and internationally. Has significant international research collaborations within the Rheumatic Heart Disease Community and within the Cardiovascular Community. Her social responsibility is reflected in, amongst others, numerous board positions; and she continues to be involved in teaching, training and mentorship encompassing courses directed at nurse practitioners, clinical officers and echocardiography masterclasses in South Africa, Ethiopia, Zambia and Uganda.